SAFETY, EVIDENCE & FDA CONSIDERATIONS
Good questions.
Informed decisions.
Understanding the evidence is part of understanding your options. Explore the essentials before your visit.
This page provides general education and does not offer investigational peptides as treatments.
Are all peptides FDA-approved?+
No. Some peptide-based medications have FDA-approved uses, while many other peptide substances remain investigational or unapproved. Approval applies to the exact product and its approved labeling. It does not extend to other substances, uses, or compounded preparations. Investigational substances should not be represented as established treatments.
What is the difference between an FDA-approved medication and a compounded medication?+
FDA-approved medications undergo agency review for safety, effectiveness, and quality for their labeled uses. Compounded drugs are not FDA-approved and do not undergo that premarket review. They are not approved generic versions or automatically interchangeable with approved products. Lawful compounding depends on applicable requirements and an individual medical need. Conditional enforcement discretion, where applicable, is not FDA approval or proof of clinical benefit.
What are the potential risks of peptide-based treatments?+
Risks depend on the substance, formulation, route, and individual patient. They may include allergic reactions, interactions with other medicines, and product-specific adverse effects. Injections introduce additional risks, including infection. Contamination or incorrect ingredient amounts in a compounded product can cause serious harm. Limited human evidence can leave important safety questions unanswered. Review complete safety information with a licensed provider before considering any treatment.
Does early research establish that a peptide treatment works?+
No. A proposed mechanism, laboratory result, animal study, or small preliminary human study does not establish that a treatment is safe or effective for a particular use. Meaningful assessment considers reliable human evidence for the exact substance, formulation, route, and intended use. Research-only labeling does not establish suitability for human treatment. Recovery, anti-aging, cognitive, weight-loss, or longevity benefits should not be assumed from early findings.
How does a provider determine whether a treatment is appropriate?+
A provider reviews your concerns, relevant medical history, medicines, examination or testing when appropriate, established alternatives, and the evidence and risks for the exact product. Regulatory status, lawful availability, monitoring needs, and clinical suitability also matter. Symptoms do not automatically indicate a need for a peptide product. A consultation does not guarantee a prescription, treatment eligibility, or access to an investigational substance. Share medical details only through the clinic’s appropriate secure intake process.
Additional reading: FDA: Understanding the risks of compounded drugs ↗